FORMER US President Herbert Hoover was a keen fisherman and even gave a speech once on the joy of fishing, or what he liked to call "the chance to wash one's soul with pure air".
The president, who was in office at the outset of the Great Depression, also knew a thing or two about the business aspects of fisheries and wisely advised to an audience in 1951 that fish can make "a mockery of profits and egos".
More than 60 years later the good advice still stands and should be heeded by former Santos chief executive John Ellice-Flint as he works hard to turn around commercial fisheries business Clean Seas Tuna of which he is the current chairman.
You see, Clean Seas Tuna has a major problem. It can propagate fish, in this case yellowtail kingfish, but just can't get the little buggers to grow properly, while 35 per cent of the fish stock have now died from a nasty intestinal illness called gut enteritis.
Worse still, an update provided by Clean Seas Tuna yesterday advised that the mortality rate had recently increased to 3 per cent a week among its kingfish juveniles.
Selling kingfish on the open market, where the product can fetch $15.50 a kilogram and as high as $20 a kilogram in Europe, is the company's main income source with its southern bluefin tuna operation still in its trial phase.
Chief executive Dr Craig Foster now has a major battle on his hands and the board has been forced to bring in experts to discover the cause of the gut problem, whose effects include diarrhoea. To date no other grower of kingfish that the company is aware of has encountered gut enteritis to the extent, variability and mortality rate that its fish have been hit with, and Clean Seas Tuna might have the awful honour of having a world-first discovery at its South Australian fish ponds.
Harvesting of the 2011 fish stock continues but the harvest size is less than anticipated by the company, although on the upside the prices it is getting for the kingfish are the best it has ever seen.
A strategic review has now begun at Clean Seas Tuna, which include investigating other ways of containing the kingfish stock as they grow from birth to ready for a dinner plate.
For shareholders expecting to land a winner from Clean Seas Tuna it has been a painful ride. Shares in Clean Seas Tuna hit the market in 2005 with an issue price of 50? reaching a high of $2.10 in April that year. The stock has lost 36 per cent of its value year to date and is now trading at just over 4.6? per share.
President Hoover believed that fishing "soothes our troubles". Clean Seas Tuna investors might not agree.
AFIC spends up
VETERAN stock picker Australian Foundation Investment Co it has been around since the 1920s raised $222.7 million via a convertible note issue in December and just how it is spending that money on behalf of investors is starting to emerge.
At a shareholder presentation in Tasmania it was revealed that more than $140 million of the new funds had already been invested. New stocks added to its $4 billion-plus equities portfolio include Ansell, QR National and Sydney Airport, while AFIC has also ploughed money into a range of healthcare stocks such as CSL and Ramsay Health Care, funeral company Invocare and mining waste management business Tox Free Solutions.
Insurer crunched
THE planned stockmarket listing of the Australian arm of mortgage insurer Genworth Financial has been shelved until early next near, after the insurer's profits were crunched by a jump in housing defaults.
Genworth's US parent was previously targeting the June quarter for the listing of up to a 40 per cent stake in the mortgage insurer.
Bullish estimates had put the value of a listing at as much as $850 million, although many institutions questioned whether the market could support such a valuation.
The Australian business was likely to report a modest first-quarter loss, Genworth said.
Rather than a systemic downturn in the nation's housing market, the company blamed banks and other lenders for accelerating some long-term mortgage delinquencies. A jump in natural catastrophes and downturn in some parts of the economy also caused a surge in mortgage losses.
Genworth ranks as Australia's largest mortgage insurer ahead of QBE Lenders Mortgage Insurance. Combined, the two hold a 75 per cent market share of the market.
"For the 2012 first quarter, the company expects to report elevated loss experience in Australia as lenders accelerated the processing of later-stage delinquencies from prior years through to foreclosure and claim at a higher rate and severity than expected," Genworth said.
Genworth says its liquidity and risk buffer plans were not dependent on the Australian initial public offer, with the holding company having approximately $US1.4 billion in cash and liquid securities. The delay is likely to represent a blow for Genworth's lead managers Goldman Sachs, Macquarie, UBS and CommSec.
Where there's smoke ...
SHAREHOLDERS in UXC reacted with equanimity to the news late on Tuesday that it is exposed to a $22 million lawsuit relating to the Black Saturday bushfires of 2009, with its shares closing down just 0.5? at 57? yesterday, maintaining its gains following its recent stellar run on its reorganisation last year.
UXC sold its Field Solutions unit in 2011 for more than $60 million. This unit had previously provided inspection services to SP AusNet, the operator of the high-voltage grid in Victoria.
It says it has insurance cover in place that provides bushfire protection, but given the propensity for insurers to challenge large payouts, it is perhaps surprising UXC shareholders are not on the back foot about the latest news at least until there is some clarity on the prospects of the legal action succeeding.
Frequently Asked Questions about this Article…
What is the kingfish health problem at Clean Seas Tuna and how serious is it for investors?
Clean Seas Tuna is battling a nasty intestinal illness called gut enteritis in its yellowtail kingfish. The company reported about 35% of the fish stock has died and juvenile mortality has recently risen to around 3% a week. For investors this is serious because it affects fish growth, harvest volumes and potentially future revenue until the cause is found and resolved.
How could kingfish gut enteritis affect Clean Seas Tuna’s revenue and harvest size?
Kingfish sales are Clean Seas’ main income source while its southern bluefin tuna work remains in trial phase. The article says harvesting of the 2011 stock is continuing but the harvest size is smaller than anticipated. Even though the company is getting very strong prices for its kingfish, lower volumes due to disease-related mortality can reduce total revenue and profit.
What prices is Clean Seas Tuna getting for kingfish and why does that matter?
The article notes kingfish can fetch about $15.50 per kilogram on the open market and as high as $20 per kilogram in Europe. Those high prices help margins, but they only matter if the company can produce healthy, market-sized fish — which is why the current gut enteritis outbreak is a material concern for profitability.
What steps has Clean Seas Tuna taken to tackle the gut enteritis issue?
The board has brought in experts to investigate the cause of the intestinal illness and launched a strategic review that includes exploring different ways to contain and grow the kingfish stock from birth to market size. CEO Dr Craig Foster and chairman John Ellice-Flint are leading the company’s response.
Is this gut enteritis outbreak common among other kingfish growers?
According to the article, Clean Seas is not aware of any other kingfish grower that has experienced gut enteritis with the same extent, variability and mortality rate. The company may have a world-first discovery at its South Australian fish ponds.
How has the market reacted to Clean Seas Tuna’s operational problems?
The article reports a tough ride for shareholders: Clean Seas listed in 2005, reached a high of $2.10 that April, and has since seen volatility. Year to date the stock had lost 36% of its value and was trading at just over 4.6? per share at the time of the report, reflecting investor concern about the operational issues.
What is the status of Clean Seas Tuna’s southern bluefin tuna operation?
The article states the southern bluefin tuna operation is still in its trial phase, so kingfish remains the company’s primary income source while the bluefin work is being developed.
What should everyday investors take away from Clean Seas Tuna’s situation?
Key investor takeaways are that operational and biological risks can materially affect aquaculture businesses, expert intervention and strategic reviews are important when unexpected problems arise, and such issues can drive share-price volatility. Investors should watch updates on the mortality investigation, any containment or production changes, and subsequent harvest and revenue guidance before reassessing the investment thesis.